Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;15(3):235-41.
doi: 10.1007/s10147-010-0083-4. Epub 2010 May 27.

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

Shinji Tanaka  1 , Shigeki Arii
Affiliations
Review

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

Shinji Tanaka et al. Int J Clin Oncol. 2010 Jun.

Abstract

Conventional systemic chemotherapy has been developed with so-called anti-cancer agents, essentially screened for cytotoxicity to cultured cancer cells. However, in patients with hepatocellular carcinoma (HCC), the role of chemotherapy is quite limited because most anti-cancer agents are ineffective and relatively toxic to HCC patients with chronic liver diseases. On the other hand, accumulated understanding of the molecular mechanisms regulating cancer progression has led to novel development of molecularly targeted therapies with cytostatic agents. Recently, a phase III clinical trial revealed a multi-kinase inhibitor, Sorafenib, as the first agent leading to improved overall survival of patients with advanced HCC. A new era of HCC treatment has arrived, based on identification of deranged signaling pathways of cancer cells or their microenvironment. This review summarizes the molecular hallmarks of HCC with a focus on angiogenesis, growth signals, and mitotic stress, and a novel concept "synthetic lethality" for the targeted therapy strategy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cell. 1996 Aug 9;86(3):353-64 - PubMed
    1. N Engl J Med. 2009 Jul 9;361(2):123-34 - PubMed
    1. Nature. 2005 Dec 8;438(7069):820-7 - PubMed
    1. Cell. 2009 May 29;137(5):835-48 - PubMed
    1. Nat Rev Cancer. 2005 Sep;5(9):689-98 - PubMed

MeSH terms

Substances

LinkOut - more resources